Liquid Biopsy: A Window into What Your Cancer Is Doing Right Now
Introduction In our last article we talked about why cancers can be so hard to treat, and how tumors are not the uniform masses most people picture. They are diverse,…
Why Cancers Stop Responding to Treatment: Understanding Tumor Heterogeneity and Resistance
Introduction Over the last few articles we have been taking a close look at how molecular testing is changing the way papillary thyroid cancer is diagnosed and treated. Today we…
Avoiding a Second Surgery: How Thyroid GuidePx® Can Help Patients Skip the Completion Thyroidectomy
Introduction For many patients diagnosed with papillary thyroid cancer, the first surgery is not always the only one. A significant number of people who have a lobectomy, where only part…
Molecular Risk Testing: A Smarter System for Thyroid Cancer Care
Bathe, O. F. Open Access Govt July 2026. Published on 2026-06-03 Abstract Molecular risk testing: A smarter system for thyroid cancer care. Oliver Bathe, Professor of Surgery and Oncology at…
Thyroid GuidePx®: A Smarter Way to Understand Papillary Thyroid Cancer
Introduction Papillary thyroid cancer is the most common type of thyroid cancer, and its incidence is increasing by approximately 6% every year. For most patients, the prognosis is good. But…
Gene Expression Panels: Listening to What Your Tumor Is Doing
Introduction When most people think about cancer testing, they think about looking for something specific. A mutation, a protein, a genetic change. The tests we explored in our previous articles…
Predictive Biomarkers: Matching the Right Treatment to the Right Patient
Introduction In our previous article, we explored the different categories of biomarkers used in cancer care, from those that signal disease risk to those that help monitor a patient's response…
From Lab to Clinic: The Diagnostic Tests Putting Precision Oncology into Practice
Introduction In our previous article, we explored the different types of biomarkers and why they matter in cancer care. Biomarkers can signal disease risk, confirm a diagnosis, predict how a…
Understanding Biomarkers: The Foundation of Precision Oncology
Introduction In our previous blog post, we explored some of the early breakthroughs that reshaped cancer treatment. Precision oncology is an approach to cancer treatment that is tailored to the…
Notable Early Successes in Precision Oncology: The Breakthroughs That Redefined Cancer Treatment
Introduction Precision oncology began gaining traction in the late 1990s and has since reshaped how we understand and treat cancer. Rather than classifying tumors solely by where they arise in…